$14.55
0.52% today
NYSE, Sep 16, 07:48 pm CET
ISIN
US28414H1032
Symbol
ELAN

Elanco Animal Health, Inc. Target price 2024 - Analyst rating & recommendation

Elanco Animal Health, Inc. Classifications & Recommendation:

Buy
62%
Hold
38%

Elanco Animal Health, Inc. Price Target

Target Price $19.00
Price $14.47
Potential
Number of Estimates 10
10 Analysts have issued a price target Elanco Animal Health, Inc. 2025 . The average Elanco Animal Health, Inc. target price is $19.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 8 Analysts recommend Elanco Animal Health, Inc. to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Elanco Animal Health, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Elanco Animal Health, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 4.42 4.42
0.14% 0.15%
EBITDA Margin 23.09% 20.69%
4.45% 10.40%
Net Margin -27.97% 7.78%
1,460.38% 127.82%

10 Analysts have issued a sales forecast Elanco Animal Health, Inc. 2024 . The average Elanco Animal Health, Inc. sales estimate is

$4.4b
Unlock
. This is
1.52% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$4.4b 0.97%
Unlock
, the lowest is
$4.3b 3.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $4.4b 0.14%
2024
$4.4b 0.15%
Unlock
2025
$4.6b 2.92%
Unlock
2026
$4.8b 4.78%
Unlock
2027
$5.1b 6.35%
Unlock
2028
$5.4b 5.83%
Unlock

9 Analysts have issued an Elanco Animal Health, Inc. EBITDA forecast 2024. The average Elanco Animal Health, Inc. EBITDA estimate is

$915m
Unlock
. This is
5.84% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$930m 4.32%
Unlock
, the lowest is
$872m 10.29%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $1.0b 4.32%
2024
$915m 10.27%
Unlock
2025
$998m 8.99%
Unlock
2026
$1.1b 8.83%
Unlock
2027
$1.2b 10.64%
Unlock
2028
$1.4b 12.39%
Unlock

EBITDA Margin

2023 23.09% 4.45%
2024
20.69% 10.40%
Unlock
2025
21.91% 5.90%
Unlock
2026
22.76% 3.88%
Unlock
2027
23.67% 4.00%
Unlock
2028
25.14% 6.21%
Unlock

8 Elanco Animal Health, Inc. Analysts have issued a net profit forecast 2024. The average Elanco Animal Health, Inc. net profit estimate is

$344m
Unlock
. This is
127.30% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$549m 143.53%
Unlock
, the lowest is
$-109m 91.37%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-1.2b 1,462.50%
2024
$344m 127.85%
Unlock
2025
$99.8m 70.99%
Unlock
2026
$290m 190.67%
Unlock
2027
$357m 23.20%
Unlock
2028
$820m 129.49%
Unlock

Net Margin

2023 -27.97% 1,460.38%
2024
7.78% 127.82%
Unlock
2025
2.19% 71.85%
Unlock
2026
6.08% 177.63%
Unlock
2027
7.05% 15.95%
Unlock
2028
15.28% 116.74%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -2.50 0.70
1,462.50% 128.00%
P/E 20.78
EV/Sales 2.81

8 Analysts have issued a Elanco Animal Health, Inc. forecast for earnings per share. The average Elanco Animal Health, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.70
Unlock
. This is
127.45% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.11 143.53%
Unlock
, the lowest is
$-0.22 91.37%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-2.50 1,462.50%
2024
$0.70 128.00%
Unlock
2025
$0.20 71.43%
Unlock
2026
$0.59 195.00%
Unlock
2027
$0.72 22.03%
Unlock
2028
$1.66 130.56%
Unlock

P/E ratio

Current -5.68 88.25%
2024
20.78 465.85%
Unlock
2025
71.63 244.71%
Unlock
2026
24.64 65.60%
Unlock
2027
20.00 18.83%
Unlock
2028
8.72 56.40%
Unlock

Based on analysts' sales estimates for 2024, the Elanco Animal Health, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.76 4.94%
2024
2.81 1.67%
Unlock
2025
2.73 2.84%
Unlock
2026
2.60 4.56%
Unlock
2027
2.45 5.97%
Unlock
2028
2.31 5.51%
Unlock

P/S ratio

Current 1.59 20.76%
2024
1.62 1.54%
Unlock
2025
1.57 2.84%
Unlock
2026
1.50 4.56%
Unlock
2027
1.41 5.98%
Unlock
2028
1.33 5.51%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today